Forward Therapeutics is a biopharma comapny targeting treatment of chronic inflammatory disorders.
Forward Therapeutics has raised $50.0M in total funding. The most recent round was Series A. The last funding was announced in October 2023.
Forward Therapeutics's investors include RA Capital Management, OrbiMed, Biotechnology Value Fund.
Forward Therapeutics is headquartered in Palm Beach Gardens, United States.
Forward Therapeutics is a biopharma comapny targeting treatment of chronic inflammatory disorders.
Forward Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Forward Therapeutics — Funding & Investors." VCBacked, October 31, 2023, https://www.vcbacked.co/company/forward-therapeutics. Accessed September 29, 2026.
VCBacked. (2023). Forward Therapeutics — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/forward-therapeutics
{{cite web |title=Forward Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/forward-therapeutics |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated